Literature DB >> 8033043

Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment.

J R White1, G S Gustafson, K Wimbish, J A Ingold, R J Lucas, A J Levine, R A Matter, A Martinez, F A Vicini.   

Abstract

BACKGROUND: The authors have reviewed their institution's experience with conservative surgery and radiation therapy for early stage breast cancer with the goal of defining the impact of infiltrating lobular histology (ILC) on the local recurrence rate. Also, they have examined the preoperative mammograms of the ILC patients to determine if mammographic features could be used to predict treatment outcome.
METHODS: Between January 1, 1980, and December 31, 1987, 402 cases of Stages I and II breast cancer were treated with conservative surgery and radiation therapy (BCT) at William Beaumont Hospital. Each patient had at least an excisional biopsy. Radiation consisted of 45-50 Gy to the entire breast followed by a supplemental boost dose, so that a minimum of 60 Gy was delivered to the tumor bed. Thirty cancers were classified histologically as infiltrating lobular carcinoma (ILC), 346 as infiltrating ductal carcinoma (IDC), and 26 as other. Median follow-up is 60 months.
RESULTS: There was no significant difference in 5 year actuarial local recurrence rates between ILC and IDC, 3.3 versus 4.2%, respectively, (P = not significant). Preoperative mammograms were retrospectively reviewed for 29 of the 30 ILC patients. A spiculated opacity was the most common primary mammographic finding (63%), followed by architectural distortion (17%), poorly defined opacity (7%), and negative (7%). Of the patients who had a preoperative primary mammographic finding of a spiculated opacity, 55% underwent reexcision after the initial excisional biopsy, and residual invasive carcinoma was found in 18% of the reexcision specimens. In contrast, of the patients with a primary mammographic finding of an architectural distortion, poorly defined opacity, or negative, 89% underwent reexcision after an initial excisional biopsy, and residual invasive carcinoma was found in 100% of the reexcision specimens.
CONCLUSIONS: Infiltrating lobular carcinoma does not have a worse local recurrence rate compared with IDC when each is treated with breast-conserving therapy. The primary finding on preoperative mammograms in patients with ILC may prove to be a useful tool for predicting the likelihood of residual carcinoma in the breast after initial excisional biopsy.

Entities:  

Mesh:

Year:  1994        PMID: 8033043     DOI: 10.1002/1097-0142(19940715)74:2<640::aid-cncr2820740216>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy.

Authors:  M M Moore; G Borossa; J Z Imbrie; R E Fechner; J A Harvey; C L Slingluff; R B Adams; J B Hanks
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

2.  The Impact of Preoperative Breast Magnetic Resonance Imaging on Surgical Management in Symptomatic Patients With Invasive Lobular Carcinoma.

Authors:  Brian M Moloney; Peter F McAnena; Éanna J Ryan; Ellen O Beirn; Ronan M Waldron; AnnaMarie O Connell; Sinead Walsh; Rachel Ennis; Catherine Glynn; Aoife J Lowery; Peter A McCarthy; Michael J Kerin
Journal:  Breast Cancer (Auckl)       Date:  2020-08-14

3.  Outcomes After Accelerated Partial Breast Irradiation in Women With Triple Negative Subtype and Other "High Risk" Variables Categorized as Cautionary in The ASTRO Guidelines.

Authors:  Anabel Goulding; Lina Asmar; Yunfei Wang; Shannon Tole; Lora Barke; Jodi Widner; Charles Leonard
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

4.  The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2003-08-22       Impact factor: 4.064

5.  Tumor biology of infiltrating lobular carcinoma. Implications for management.

Authors:  T J Yeatman; A B Cantor; T J Smith; S K Smith; D S Reintgen; M S Miller; N N Ku; P A Baekey; C E Cox
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

6.  Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-Year results.

Authors:  János Fodor; Tibor Major; József Tóth; Zoltán Sulyok; Csaba Polgár
Journal:  Rep Pract Oncol Radiother       Date:  2011-07-27

7.  Present and changing trends in surgical modalities and neoadjuvant chemotherapy administration for female breast cancer in Beijing, China: A 10-year (2006-2015) retrospective hospitalization summary report-based study.

Authors:  Xiaoyuan Bao; Kexin Sun; Xin Tian; Qiongzhou Yin; Meng Jin; Na Yu; Hanfang Jiang; Jun Zhang; Yonghua Hu
Journal:  Thorac Cancer       Date:  2018-04-06       Impact factor: 3.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.